EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Pharmacokinetic and Safety Profiles of MIT-001, a Novel Ferroptosis Inhibitor, After Subcutaneous Administration in Healthy Participants

Sujong Lee iD, Sungyeun Bae iD, Kyung-Sang Yu iD, SeungHwan Lee iD

Drug Design, Development and Therapy · 2025-09 · Volume 19 · 7999-8008

DOI: 10.2147/dddt.s541415 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2025-09. Verfasst von Sujong Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Ferroptosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisAdultFemaleHumansMaleMiddle AgedYoung AdultCross-Over StudiesDose-Response Relationship, DrugDouble-Blind MethodHealthy VolunteersInjections, Subcutaneous

Stichwörter der Autor:innen

MIT-001bioavailabilitypharmacokineticssafetysubcutaneoustolerability

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
  • Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Sujong Lee, Sungyeun Bae, Kyung-Sang Yu, SeungHwan Lee

Zitieren

APA

Lee, S., Bae, S., Yu, K. S., & Lee, S. (2025). Pharmacokinetic and Safety Profiles of MIT-001, a Novel Ferroptosis Inhibitor, After Subcutaneous Administration in Healthy Participants. Drug Design, Development and Therapy, Volume 19, 7999-8008. https://doi.org/10.2147/dddt.s541415

Vancouver

Lee S, Bae S, Yu KS, Lee S. Pharmacokinetic and Safety Profiles of MIT-001, a Novel Ferroptosis Inhibitor, After Subcutaneous Administration in Healthy Participants. Drug Design, Development and Therapy. 2025;Volume 19:7999-8008. doi:10.2147/dddt.s541415

BibTeX
@article{Lee2025,
  author = {Lee, Sujong and Bae, Sungyeun and Yu, Kyung-Sang and Lee, SeungHwan},
  title = {Pharmacokinetic and Safety Profiles of MIT-001, a Novel Ferroptosis Inhibitor, After Subcutaneous Administration in Healthy Participants},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {7999--8008},
  doi = {10.2147/dddt.s541415}
}
Kostenlos starten →